Our mission - is to facilitate the transition of the Russian pharmaceutical market to develop into mature, be a guide on the course of development of the potential of all the pharmaceutical market participants, thereby improving the quality of life for the end user and society in general. Despite the relatively high susceptibility to Russia's external economic and financial risks, imbalances in the domestic policy and great social disparities, the pharmaceutical market in Russia has had a stable positive growth for the last few years.
In St. Petersburg, the VII International Partnering Forum "Life Science Invest. Partnering Russia ». Within the framework of the event, the session "Development of the domestic pharmaceutical market under the conditions of import substitution and localization of production" was held, at which the Director General of the ARPF Viktor Dmitriev analyzed the topical issues of the pharmaceutical industry.
The upcoming VIII All-Russian Congress of Patients, which will begin on November 29 in Moscow, will bring to the public discussion areas the most pressing and pressing issues of modern domestic health care. The main theme is the execution of presidential decrees in the sphere of saving the nation's health.
November 15, 2017 in Vladivostok, the forum "Health Industry - the Far East 2017" will be held, which will bring together representatives of the pharmaceutical industry of the Far Eastern Federal District. Within the framework of the forum, experts will discuss the issues of drug provision and the current problems of pharmaceutical activity in the region.
Director General of ARPF Viktor Dmitriev, speaking at the forum, spoke about the preliminary results of the implementation of the "Pharma-2020" program. "For 8 months of 2017, the level of retail prices for medicines on the VED list fell by 0.9%. The prices for VED of domestic production decreased by 1.5%, and for foreign production - by 0.4%. Reduction in the level of retail prices for VED in the price category "up to 50 rubles" was 1.4%, in the category "from 50 rubles to 500 rubles" - 0.8%, and in the category "over 500 rubles" - 0.4%. The average increase in the price level for drugs not included in the VED was 8.9%.
We are glad to inform you that the 3rd Annual "FACT Plus2018" - the International Forum of Anti-Coagulant and Antiaggregant Therapy, dedicated to the promotion of professional assistance to patients with thromboembolic complications, will be held March 22-24, 2018 in Moscow in the hotel complex "Golden Ring", at the address: Moscow, Smolenskaya, 5.
On October 19, the day of the 100th anniversary of the Chamber of Commerce and Industry, a traditional business breakfast was held at Ilyinka in the Chamber of Commerce and Industry of the Russian Federation. The guest of the meeting was the head of the Federal Customs Service Vladimir Bulavin.
On November 23, the solemn presentation of the national award in the field of pharmacy and medicine Russian Pharma Awards - 2017 will take place at the Mir banquet hall, during which the best medicines of the outgoing year will be announced. Within the framework of this event, for the sixth consecutive year the professional community of Russian doctors has chosen the leaders of the country's pharmaceutical market.